Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine Demand
Question
Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine Demand
Direct answer
Bavarian Nordic announced an upward revision to its 2026 financial expectations, citing higher demand volumes across its commercial Travel Health portfolio. The primary catalyst behind the DKK 400 million guidance boost is US commercial distribution for rabies prevention following increased domestic animal exposure rates.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-08
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine Demand”, revision 1, evidence through 2026-10-08. https://marketontology.com/market-events/2026-10-08/bavarian-nordic-lifts-2026-revenue-outlook-on-us-vaccine-demand-c9dc6c
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| BVNRY | operating revenue expansion from specialty vaccine demand | Up1-3m | Bavarian Nordic raised Travel Health revenue expectations to DKK 3,400 million from DKK 3,000 million. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| BVNRY | Upagreed | 11.48 2026-10-08 | +2.61% | Pending | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-19Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capitalBVNRY
- 2026-10-19Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capitalBVNRY
- 2026-10-08Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine DemandBVNRY+2.61%
- 2026-10-08Bavarian Nordic raises 2026 Travel Health outlook to DKK 3.4B on US rabies vaccine salesBVNRY+2.61%
- 2026-10-08Bavarian Nordic Raises 2026 Guidance on U.S. Travel Health Revenue StrengthBVNRY+2.61%
- 2026-10-08Bavarian Nordic Raises 2026 Travel Health Revenue Guidance to DKK 3.4BBVNRY+2.61%
- 2026-10-08Bavarian Nordic Raises 2026 Guidance on U.S. Travel Health Revenue StrengthBVNRY+2.61%
- 2026-10-08Bavarian Nordic Lifts 2026 Travel Health Revenue Guidance to DKK 3.4BBVNRY+2.61%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.